Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until ...

Despite newer TB drugs, delayed diagnosis, atypical symptoms and drug resistance continue to complicate treatment ...

Please provide your email address to receive an email when new articles are posted on . Experts say that people with HIV should be included in clinical trials for new tuberculosis vaccine candidates ...

Faculty investigators from UB’s Center for Integrated Global Biomedical Sciences (CIGBS) recently traveled to Zimbabwe and South Africa to address two public health challenges devastating that part of ...

The latest World Health Organization's Global Tuberculosis Report released in November 2024 painted a sobering picture; approximately 8.2 million people were newly diagnosed with tuberculosis (TB) in ...

New study supports QuantiFERON-TB Gold Plus use in immunocompromised and other high-risk populations in various settings Findings show QuantiFERON testing is cost-effective compared with tuberculin ...

Tuberculosis (TB) remains the leading cause of death among people living with HIV. Although HIV-1 and Mycobacterium tuberculosis (Mtb) coinfection remains a major public health concern, this problem ...

Existing treatments control TB and HIV, but the immune system does not revert to normal, helping explain why people living with HIV remain susceptible to infections and underscoring the need for ...

With determined leadership and smart use of current and future innovations, we can sustain momentum and accelerate progress ...

I am writing in reference to the recent article on linking the control and treatment of tuberculosis (TB) and HIV in developing countries. [1] Although the World Health Organization has provided ...

Community health worker Marc Ilboudo uses a mobile application during a consultation with a child in Pousghin, Burkina Faso. The heads of state and government from nearly 200 countries gathering this ...

Harriet Mayanja-Kizza is based at the Uganda CWRU Research Collaboration (UCRC) - a Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) Partner Site. She receives funding from NIH, ...